<html>
<head>
<META http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>Feedback inhibition of glycolysis by ATP</title>
<meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no"/>
<script type="text/javascript" src="../javascript/halo-common.js"></script>
<link rel="stylesheet" type="text/css" href="../css/halo-common.css"/>
<link rel="stylesheet" href="../css/glossary.css" type="text/css" />
</head>
<body>

  <div id="glossary-page" class="glossary-page">


<h2>Feedback inhibition of glycolysis by ATP</h2>


<div id="shortdef" class="content-summary" style="display:none;">


                                                                 <h3>feedback inhibition of glycolysis by ATP
                                                                 </h3>


  <p class="human-authored">A method of metabolic control of glycolysis in which excess ATP molecules produced during glycolysis act as an inhibitor of phosphofructokinase (PFK), an enzyme within the glycolytic pathway.
  </p>

</div>
      <div id="definition" class="definition">


        <h3>Definition of a feedback inhibition of glycolysis by ATP
        </h3>


        <p>A method of metabolic <a class="keywords" href="../glossary/Control-Of-Glycolysis.html">control of glycolysis</a> in which excess <a class="keywords" href="../glossary/ATP.html">ATP</a> <a class="keywords" href="../glossary/Molecule.html">molecules</a> produced during glycolysis act as an <a class="keywords" href="../glossary/Inhibitor.html">inhibitor</a> of <a class="keywords" href="../glossary/Phosphofructokinase.html">phosphofructokinase</a> (PFK), an <a class="keywords" href="../glossary/Enzyme.html">enzyme</a> within the glycolytic pathway.
        </p>

<p>
<a class="keywords"
 href=
   "./Feedback-Inhibition-Of-Glycolysis-By-ATP.html">Feedback inhibition of glycolysis by ATP
</a> is a type of: 
<a class="keywords"
 href=
   "./Feedback-Inhibition-Of-Glycolysis.html">feedback inhibition of glycolysis
</a>.
</p>

        <table cellpadding="0" cellspacing="0">

          <tr align="left" valign="top">

            <td><!--  table of contents's cell -->

              <ul id="toc">

                <h3>Contents</h3>

                <li>
                  <a class="toc-link" href="#function">Function</a>
                </li>

                <li><a class="toc-link" href="#media">Media</a></li>

              </ul>
              <a id="show-graph-button" style=""
               href=
                 "Feedback-Inhibition-Of-Glycolysis-By-ATP_RelationGraph.html">concept map
              </a>

            </td><!-- end table of contents's cell -->

            <td><!-- image's cell -->
<div class="fig" id="fig7_3">
<div class="fig-caption">
<div class="fig-title"><a href="../book/figures/figure7-3.html">Figure 7.3</a> </div><!-- figure title ends -->
<div class="fig-text">  A Signal and Its Receptor 
 
  (A)  The adenosine 2A receptor occurs in the human brain, where it is involved in inhibiting active wakefulness.  (B)  Adenosine is the normal (endogenous) ligand for the receptor. Caffeine has a structure similar to that of adenosine and can act as an antagonist that binds the receptor and prevents its normal functioning.</div><!-- figure text ends -->
</div><!-- figure caption ends -->
<a href="../book/figures/figure7-3.html"><img class="fig-image" alt="Figure 7.3" src="../thumb/figure7/fig7_3.png"></img></a>
</div><!-- fig ends -->

            </td><!-- end image's cell -->

          </tr>

        </table>

      </div>

            <h3>Mechanisms</h3>
            <ul>
              <ul>

                <li><a class="keywords" href="../glossary/Collecting.html">collecting</a>
                </li>

              </ul>
            </ul>

                 <h3>Participants of a feedback inhibition of glycolysis by ATP
                 </h3>
                 <p>Inhibition by a <a class="keywords" href="../glossary/Chemical-Entity.html">chemical</a> (an <a class="keywords" href="../glossary/Inhibitor.html">inhibitor</a>) in a <a class="keywords" href="../glossary/Cell.html">cell</a>
                 </p>
<script type="text/javascript">
function loadGraph(callbackFn) {
$.getScript("../javascript/raphael-min.js", function(data, textStatus){
$.getScript("../javascript/dracula_graph.js", function(data, textStatus){
$.getScript("../javascript/dracula_graffle.js", function(data, textStatus){
$.getScript("../javascript/relationship_answer_graph.js", function(data, textStatus){
buildGraph(); setClassForGraphLinks("keywords"); if (callbackFn instanceof Function) { callbackFn(); }});});});});
}

function buildGraph() {
}
</script>
<div id="media">
<h3>Media</h3>
<div class="fig" id="fig7_3">
<div class="fig-caption">
<div class="fig-title"><a href="../book/figures/figure7-3.html">Figure 7.3</a> </div><!-- figure title ends -->
<div class="fig-text">  A Signal and Its Receptor 
 
  (A)  The adenosine 2A receptor occurs in the human brain, where it is involved in inhibiting active wakefulness.  (B)  Adenosine is the normal (endogenous) ligand for the receptor. Caffeine has a structure similar to that of adenosine and can act as an antagonist that binds the receptor and prevents its normal functioning.</div><!-- figure text ends -->
</div><!-- figure caption ends -->
<a href="../book/figures/figure7-3.html"><img class="fig-image" alt="Figure 7.3" src="../thumb/figure7/fig7_3.png"></img></a>
</div><!-- fig ends -->
<div class="fig" id="fig7_15">
<div class="fig-caption">
<div class="fig-title"><a href="../book/figures/figure7-15.html">Figure 7.15</a> </div><!-- figure title ends -->
<div class="fig-text">  A Cascade of Reactions Leads to Altered Enzyme Activity 
 
 Liver cells respond to epinephrine by activating G proteins, which in turn activate the synthesis of the second messenger cAMP. Cyclic AMP initiates a protein kinase cascade, greatly amplifying the epinephrine signal, as indicated by the bold, black numbers. The cascade both inhibits the conversion of glucose to glycogen and stimulates the release of previously stored glucose. 
 </div><!-- figure text ends -->
</div><!-- figure caption ends -->
<a href="../book/figures/figure7-15.html"><img class="fig-image" alt="Figure 7.15" src="../thumb/figure7/fig7_15.png"></img></a>
</div><!-- fig ends -->
</div><!-- end media --><div ID="further-reading" CLASS="glossary-section">
<h3>Further reading</h3>
<ul>
<li><span HREF="../book/chapter5/chapter5-2.html"><strong>5.2 </strong>Eukaryotic Cells Contain Organelles
<ul CLASS="inline">
<li><a HREF="../book/chapter5/chapter5-3.html#section5-0-5" CLASS="text-ref">Biologists can manipulate living systems to establish cause and effect</a></li> <span CLASS="concepts">(<a class="keywords" href="../glossary/Cell.html">cell</a>)</span>
</ul>
</span></li><li><span HREF="../book/chapter8/chapter8-4.html"><strong>8.4 </strong>Enzyme Activities Can Be Regulated
<ul CLASS="inline">
<li><a HREF="../book/chapter8/chapter8-5.html#PAR-ID-69" CLASS="text-ref">temperature affects enzyme activity</a></li>
</ul>
</span></li><li><span HREF="../book/chapter11/chapter11-6.html"><strong>11.6 </strong>Unregulated Cell Division Can Lead to Cancer
<ul>
<li><a HREF="../book/chapter11/chapter11-summary.html" CLASS="text-ref">11 Chapter Summary</a> <span CLASS="concepts">(<a class="keywords" href="../glossary/Cell.html">cell</a>)</span></li>

<li><a HREF="../book/chapter11/chapter11-7.html#PAR-ID-9" CLASS="text-ref">Cancer cells lose control over the cell cycle and apoptosis</a> <span CLASS="concepts">(<a class="keywords" href="../glossary/Cell.html">cell</a>)</span></li>
</ul></span></li>
</ul></div>
  </div><!-- end glossary-page -->

</body>
</html>

